Yearly Publication Trends - drug discovery

Year	Publication Count
2024	10693
2023	61660
2022	43385
2021	28489
2020	24067
2019	20230
2018	15487
2017	15866
2016	16160
2015	16022
2014	15992

Relevant Publications

PepExplainer: An explainable deep learning model for selection-based macrocyclic peptide bioactivity prediction and optimization.

Issue Release: 2024

Anti-amyloid-β Antibodies and Anti-tau Therapies for Alzheimer\'s Disease: Recent Advances and Perspectives.

Issue Release: 2024

Single-step 3D bioprinting of alginate-collagen I hydrogel fiber rings to promoter angiogenic network formation.

Issue Release: 2024

Flavonoidal alkaloids: Emerging targets for drug discovery from Nature\'s bounty.

Issue Release: 2024

Evaluation of ComBat harmonization for reducing across-tracer biases in regional amyloid PET analyses.

Issue Release: 2024

Graph-Based Bidirectional Transformer Decision Threshold Adjustment Algorithm for Class-Imbalanced Molecular Data.

Issue Release: 2024

Towards a dependable data set of structures for L-asparaginase research.

Issue Release: 2024

Structure-activity relationship of anticancer and antiplasmodial gold bis(dithiolene) complexes.

Issue Release: 2024

Alterations of apparent diffusion coefficient from ultra high b-values in the bilateral thalamus and striatum in MRI-negative drug-resistant epilepsy.

Issue Release: 2024

Corrigendum to \"Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning\" [eBioMedicine, 2022;83:104214].

Issue Release: 2024

Population sequencing for diversity and transmission analyses.

Issue Release: 2024

Discovery of putative inhibitors of human Pkd1 enzyme: Molecular docking, dynamics and simulation, QSAR, and MM/GBSA.

Issue Release: 2024

Discovery of antimicrobial peptides in the global microbiome with machine learning.

Issue Release: 2024

Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.

Issue Release: 2024

Antibacterial properties of natural products from marine fungi reported between 2012 and 2023: a review.

Issue Release: 2024

An end-to-end method for predicting compound-protein interactions based on simplified homogeneous graph convolutional network and pre-trained language model.

Issue Release: 2024

The Pan-Canadian Chemical Library: A Mechanism to Open Academic Chemistry to High-Throughput Virtual Screening.

Issue Release: 2024

The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.

Issue Release: 2024

Alternate recognition by dengue protease: Proteolytic and binding assays provide functional evidence beyond an induced-fit.

Issue Release: 2024

Structure-based virtual screening of vast chemical space as a starting point for drug discovery.

Issue Release: 2024

What Are the Challenges of Clinical Trials?

What is Pharma?

How Do Collaborative Care Models Work?

What Causes Adverse Drug Events?

Why is the Management of Chronic Conditions Important?

How Can Pharma Companies Improve Patient Education?

What are the Phases of Clinical Trials?

Why is Geriatric Care Important?

What Challenges Do Pharmacists Face?

What are the Implications for Pharma Companies?

Partnered Content Networks

Relevant Topics